tirzepatide news Lilly's new drug Mounjaro (tirzepatide ) wins US FDA approval Eli Lilly sues companies selling

While first- and second-generation options only target one or two of these pathways, Retatrutides triple-action mechanism completely redefines what is possible for chronic weight management and metabolic restoration

GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have become essential tools for managing diabetes and weight loss

This occurs because of structural similarities in epitopes, which can lead to immune recognition across different proteins

If we want to protect both patients and data integrity, we need to make GLP-1 research more accessible, not more exclusive

Results Overall, 683 participants were randomised using a Randomisation and Trial Supply Management system to IcoSema (n=342) or semaglutide 1.0 mg (n=341)